Tweet
Has anyone heard anymore about this treatment?
Cystic Fibrosis Drug to Be Tested as Dry Eye Treatment
CHAPEL HILL, N.C., March 2005 — A new drug that may hydrate the eye's surface to help ease dry eye symptoms has received U.S. Food and Drug Administration clearance to begin clinical trials aimed at proving its effectiveness, Lantibio Inc. announced.
The drug, Moli1901, initially was developed as a cystic fibrosis treatment, company director of development Terry Laliberte said in a news release. The drug treats cystic fibrosis by altering the way lungs form mucus, creating a more normal environment in airways.
The release says Moli1901 may potentially moisten the eye's surface to relieve dry eye symptoms such as irritation, discomfort, and long-term effects that might lead to eye injury.
About 5.5 million U.S. residents are estimated to have dry eye syndrome, which occurs more often in women, primarily due to hormone changes associated with menopause.
Cystic Fibrosis Drug to Be Tested as Dry Eye Treatment
CHAPEL HILL, N.C., March 2005 — A new drug that may hydrate the eye's surface to help ease dry eye symptoms has received U.S. Food and Drug Administration clearance to begin clinical trials aimed at proving its effectiveness, Lantibio Inc. announced.
The drug, Moli1901, initially was developed as a cystic fibrosis treatment, company director of development Terry Laliberte said in a news release. The drug treats cystic fibrosis by altering the way lungs form mucus, creating a more normal environment in airways.
The release says Moli1901 may potentially moisten the eye's surface to relieve dry eye symptoms such as irritation, discomfort, and long-term effects that might lead to eye injury.
About 5.5 million U.S. residents are estimated to have dry eye syndrome, which occurs more often in women, primarily due to hormone changes associated with menopause.
Comment